MiNK Therapeutics Inc. (NASDAQ: INKT)
$6.5150
+1.0050 ( +10.65% ) 49.8K
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Market Data
Open
$6.5150
Previous close
$5.5100
Volume
49.8K
Market cap
$23.62M
Day range
$5.7500 - $6.6250
52 week range
$4.5601 - $19.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jan 21, 2025 |
| def | Proxies and info statements | 3 | Dec 20, 2024 |
| 4 | Insider transactions | 1 | Dec 09, 2024 |
| 3 | Insider transactions | 1 | Dec 09, 2024 |
| pre | Proxies and info statements | 3 | Dec 06, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Dec 03, 2024 |
| 10-q | Quarterly Reports | 53 | Nov 14, 2024 |